Hospital-Acquired Disease Testing Market - By Testing Type (Urinary Tract Infection, Surgical Site Infection, Pneumonia Stents, Blood Stream Infection, Methicillin-resistant Staphylococcus Aureus (MRSA)) - Global Opportunity Analysis and Industry Forecast, 2020 – 2030

Hospital-Acquired Disease Testing Market held USD 1108.6 million in 2020 and is to grow with a CAGR of over 19.8% from 2020-2030. Hospital-acquired disease and nosocomial infection is a localized or general condition in patients that occurs during medical care due to adverse reactions caused by infectious toxin agents, which were absent at admission in hospitals. Hospital-acquired infections result in prolonged hospital stay, resistance to antimicrobials, long-term disabilities and increased mortality rates. Hospital-acquired disease-causing pathogens include viruses, fungal parasites and bacteria. Hospital-acquired diseases also include catheter-related infections of the blood stream, infections of the surgical site, ventilator-associated pneumonia, and urinary tract-associated infection.

Market Dynamics and Factors:

Major driving factors for the market are increased government spending on the healthcare and medical sector, growth of hospital infrastructure in developing economies. Rapid and effective infection detection solutions not only help control the incidence of nosocomial infections but also control overall medical costs, hospital stays and death. Widespread availability of more sophisticated solutions for detecting infections, especially those under molecular diagnostics, and their proven efficiency in delivering faster results has resulted in increased demand for such products worldwide. Government initiatives and hospital-acquired infection control authorities focusing on boosting awareness about hospital-acquired infection and available therapies further drive demand for hospital-acquired infection tests. Furthermore, increasing prevalence of hospital acquired infections and growth in drug resistant pathogens is anticipated to drive the hospital acquired infection testing market trends.

Market Segmentation:

Based on the testing type, the hospital-acquired disease testing market industry is segmented into methicillin-resistant staphylococcus aureus (MRSA), urinary tract infection, pneumonia stents, blood stream infection, surgical site infection and others. Geographical breakdown and analysis of each of the aforementioned segments includes regions comprising North America, Europe, Asia-Pacific, and RoW.

Geographic Analysis:

North America dominates the hospital-acquired disease testing market share with the large demand owing to advanced healthcare infrastructure. As per U.S. Department of Health and Human Services, hospital acquired infection prevention costs nearly around US$ 28.0 Bn to US$ 33.0 Bn per year. Therefore, to lower the burden on hospitals occurring due to prolonged patients stay in hospitals, many governments are taking steps to lower hospital acquired infection prevalence in the particular countries.

Competitive Scenario:

Global hospital-acquired disease testing market, is highly competitive, consists of a few major players. In terms of market share, currently few players hold the majority of the hospital-acquired disease testing market. Key companies are also expanding their manufacturing facilities to cater to growing demand for this drug globally. Key players enhancing the global Hospital-acquired disease testing market size include Hologic, Inc, bioMérieux SA, Abbott Laboratories, Siemens Healthcare, Alere, Inc., Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Hoffmann-La Roche Ltd, Diatherix Laboratories, Inc., Meridian Bioscience, Inc.

In 2019, F.Hoffmann-La Roche Ltd. grabbed U.S.. Food and Drug Administration (FDA) approval for a diagnostic test designed to detect the Methicillin-resistant Staphylococcus aureus (MRSA) bacteria, known as cobas vivoDx MRSA. The approval of is intended to control and prevent Methicillin-resistant Staphylococcus aureus (MRSA) infections occurred in patients after long stay in hospitals.

Hospital-Acquired Disease Testing Market Report Scope